191 related articles for article (PubMed ID: 21325633)
1. Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling.
Deeb D; Gao X; Liu Y; Jiang D; Divine GW; Arbab AS; Dulchavsky SA; Gautam SC
Carcinogenesis; 2011 May; 32(5):757-64. PubMed ID: 21325633
[TBL] [Abstract][Full Text] [Related]
2. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
Deeb D; Gao X; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer.
Gao X; Deeb D; Liu Y; Arbab AS; Divine GW; Dulchavsky SA; Gautam SC
Cancers (Basel); 2011; 3(3):3353-69. PubMed ID: 21961053
[TBL] [Abstract][Full Text] [Related]
4. Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer.
Liu Y; Gao X; Deeb D; Arbab AS; Gautam SC
Molecules; 2012 Dec; 17(12):14795-809. PubMed ID: 23519253
[TBL] [Abstract][Full Text] [Related]
5. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.
Deeb D; Gao X; Jiang H; Dulchavsky SA; Gautam SC
Prostate; 2009 Jun; 69(8):851-60. PubMed ID: 19189297
[TBL] [Abstract][Full Text] [Related]
6. CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells.
Deeb D; Gao X; Dulchavsky SA; Gautam SC
Anticancer Res; 2007; 27(5A):3035-44. PubMed ID: 17970042
[TBL] [Abstract][Full Text] [Related]
7. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
[TBL] [Abstract][Full Text] [Related]
8. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R
Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.
Hyer ML; Shi R; Krajewska M; Meyer C; Lebedeva IV; Fisher PB; Reed JC
Cancer Res; 2008 Apr; 68(8):2927-33. PubMed ID: 18413762
[TBL] [Abstract][Full Text] [Related]
10. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling.
Gao X; Deeb D; Jiang H; Liu Y; Dulchavsky SA; Gautam SC
J Neurooncol; 2007 Sep; 84(2):147-57. PubMed ID: 17361329
[TBL] [Abstract][Full Text] [Related]
11. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
Narayanan BA; Narayanan NK; Pittman B; Reddy BS
Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
[TBL] [Abstract][Full Text] [Related]
12. Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-{kappa}B signaling proteins in colorectal cancer cells.
Gao X; Deeb D; Hao J; Liu Y; Arbab AS; Dulchavsky SA; Gautam SC
Anticancer Res; 2010 Mar; 30(3):785-92. PubMed ID: 20392997
[TBL] [Abstract][Full Text] [Related]
13. Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-κB/mTOR signaling.
Gao X; Liu Y; Deeb D; Arbab AS; Guo AM; Dulchavsky SA; Gautam SC
Anticancer Res; 2011 Nov; 31(11):3673-81. PubMed ID: 22110186
[TBL] [Abstract][Full Text] [Related]
14. CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma.
Gao X; Deeb D; Liu Y; Liu P; Zhang Y; Shaw J; Gautam SC
Int J Oncol; 2015 Dec; 47(6):2100-6. PubMed ID: 26497549
[TBL] [Abstract][Full Text] [Related]
15. ROS mediate proapoptotic and antisurvival activity of oleanane triterpenoid CDDO-Me in ovarian cancer cells.
Gao X; Liu Y; Deeb D; Liu P; Liu A; Arbab AS; Gautam SC
Anticancer Res; 2013 Jan; 33(1):215-21. PubMed ID: 23267148
[TBL] [Abstract][Full Text] [Related]
16. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells.
Stadheim TA; Suh N; Ganju N; Sporn MB; Eastman A
J Biol Chem; 2002 May; 277(19):16448-55. PubMed ID: 11880365
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells.
Kim KB; Lotan R; Yue P; Sporn MB; Suh N; Gribble GW; Honda T; Wu GS; Hong WK; Sun SY
Mol Cancer Ther; 2002 Jan; 1(3):177-84. PubMed ID: 12467212
[TBL] [Abstract][Full Text] [Related]
18. Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid.
Wu T; Ye Y; Min SY; Zhu J; Khobahy E; Zhou J; Yan M; Hemachandran S; Pathak S; Zhou XJ; Andreeff M; Mohan C
Arthritis Rheumatol; 2014 Nov; 66(11):3129-39. PubMed ID: 25047252
[TBL] [Abstract][Full Text] [Related]
19. Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma.
Kress CL; Konopleva M; Martínez-García V; Krajewska M; Lefebvre S; Hyer ML; McQueen T; Andreeff M; Reed JC; Zapata JM
PLoS One; 2007 Jun; 2(6):e559. PubMed ID: 17593960
[TBL] [Abstract][Full Text] [Related]
20. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathway.
Ray DM; Morse KM; Hilchey SP; Garcia TM; Felgar RE; Maggirwar SB; Phipps RP; Bernstein SH
Exp Hematol; 2006 Sep; 34(9):1202-11. PubMed ID: 16939813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
